These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 32692894)
1. Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders? Macciò A; Madeddu C; Caocci G; La Nasa G J Thromb Haemost; 2020 Nov; 18(11):3106-3108. PubMed ID: 32692894 [No Abstract] [Full Text] [Related]
2. Response to Maccio et al, "Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?". Richardson E; Carlo-Stella C; Jara R; Vlodavsky I; Iacobelli M; Fareed J; Mo C; O'Gorman P; Yanik G; Palomo M; Diaz-Ricart M; Moraleda JM; J Thromb Haemost; 2020 Nov; 18(11):3111-3113. PubMed ID: 32860297 [No Abstract] [Full Text] [Related]
3. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study. Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475 [TBL] [Abstract][Full Text] [Related]
4. Contribution value of coagulation abnormalities in COVID-19 prognosis: a bright perspective on the laboratory pattern of patients with coronavirus disease 2019. Sayyadi M; Khosravi M; Ghaznavi-Rad E Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):518-522. PubMed ID: 33506943 [TBL] [Abstract][Full Text] [Related]
5. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19. Dobesh PP; Trujillo TC Pharmacotherapy; 2020 Nov; 40(11):1130-1151. PubMed ID: 33006163 [TBL] [Abstract][Full Text] [Related]
6. Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned? Iba T; Levy JH; Maier CL; Connors JM; Levi M J Thromb Haemost; 2024 Jun; 22(6):1541-1549. PubMed ID: 38428590 [TBL] [Abstract][Full Text] [Related]
7. Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy? Mohamed-Hussein AAR; Aly KME; Ibrahim MAA Med Hypotheses; 2020 Nov; 144():109975. PubMed ID: 32531536 [No Abstract] [Full Text] [Related]
8. A proposal for the management of COVID-19-induced coagulopathy in adults. Ignacio-Ibarra G; García-Lee MT; González-Ávila AI; García-Chávez J; Guzmán-Chores L; Cruz CL; Lugo-García Y; Juárez-Lara J; García-Vázquez M; Madera-Maldonado CE; Ramos-Peñafiel CO; Majluf-Cruz A Gac Med Mex; 2021; 157(2):201-206. PubMed ID: 34270538 [TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Asakura H; Ogawa H Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508 [TBL] [Abstract][Full Text] [Related]
10. Haematological manifestations of COVID-19: From cytopenia to coagulopathy. Agbuduwe C; Basu S Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356 [TBL] [Abstract][Full Text] [Related]
11. Point-of-Care Coagulation Tests Monitoring of Direct Oral Anticoagulants and Their Reversal Therapy: State of the Art. Iapichino GE; Bianchi P; Ranucci M; Baryshnikova E Semin Thromb Hemost; 2017 Jun; 43(4):423-432. PubMed ID: 28346965 [TBL] [Abstract][Full Text] [Related]
12. Interference of anticoagulants on coagulation testing. van de Kerkhof D; Schmitz E; Moolenaar M; Schellings M; Boer AK; Boonen K Clin Chem Lab Med; 2016 Jul; 54(7):e207-10. PubMed ID: 26824980 [No Abstract] [Full Text] [Related]